Skip to main content
. 2023 Oct 19;12(11):2595–2609. doi: 10.1007/s40121-023-00872-4

Table 2.

Virological response rates during and after treatment

Response Patients
During treatment
 At week 4 269/326 (82.5% [77.9%,86.5%])
 At week 12 314/326 (96.3% [93.7%,98.1%])
Post-treatment
 At week 4 320/326 (98.2% [96.0%,99.3%])
 At week 12 321/326 (98.5% [96.5%,99.5%])
 At week 24 320/326 (98.2% [96.0%,99.3%])

Data are n/N (% [95% CI]). Response was defined as hepatitis C virus RNA < 15 IU/mL